Research Shows Twice-a-Year Drug Could Suppress Drug-Resistant HIV

Reading now: 639

lenacapavir, the biopharmaceutical company’s drug that may help people living with multi-drug resistant HIV.Lenacapavir is an injection for patients to take every six months.

Researchers found that after Week 26, lenacapavir, taken with antiretrovirals, suppressed HIV in those that had not been previously responding to such treatment, according to a press release.The results were presented at the 11th International AIDS Society Conference on HIV Science.“Despite the advances in treating HIV infection, there remains an unmet need for treatment options for people who struggle with multi-drug resistance.

The website is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News